Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Urretavizcaya

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Actas Espanolas De Psiquiatria|November 21, 2009
[Circadian rhythms and depression]V Soria, M Urretavizcaya
Journal of Affective Disorders|May 10, 2003
Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitudeM Urretavizcaya, I Moreno, L Benlloch, et al.
Psychiatry Research|November 9, 2000
Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victimsP Rosel, B Arranz, L San, et al.
Journal of Affective Disorders|September 3, 2002
Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patientsJ Vallejo, P Rosel, B Arranz, et al.
Biological Psychiatry|November 15, 1996
Seasonal variability in blood platelet 3H-imipramine binding in healthy controls: age and gender effectsP R Soria, J Vallejo, M Oros, et al.
Psychological Medicine|March 1, 1996
Growth hormone response to growth hormone releasing hormone in non-delusional and delusional depression and healthy controlsF Contreras, M A Navarro, J M Menchon, et al.
Journal of Endocrinological Investigation|March 28, 2020
Vitamin D status and response to growth hormone treatment in prepubertal children with growth hormone deficiencyT Durá-Travé, F Gallinas-Victoriano, P Moreno-González, et al.
The Pharmacogenomics Journal|May 17, 2007
A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disordersM Gratacòs, V Soria, M Urretavizcaya, et al.
Genes, Brain, and Behavior|July 13, 2010
A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depressionE Saus, V Soria, G Escaramís, et al.
Translational Psychiatry|February 8, 2017
Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging studyM Cano, I Martínez-Zalacaín, Á Bernabéu-Sanz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Actas Espanolas De Psiquiatria|November 21, 2009
[Circadian rhythms and depression]V Soria, M Urretavizcaya
Journal of Affective Disorders|May 10, 2003
Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitudeM Urretavizcaya, I Moreno, L Benlloch, et al.
Psychiatry Research|November 9, 2000
Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victimsP Rosel, B Arranz, L San, et al.
Journal of Affective Disorders|September 3, 2002
Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patientsJ Vallejo, P Rosel, B Arranz, et al.
Biological Psychiatry|November 15, 1996
Seasonal variability in blood platelet 3H-imipramine binding in healthy controls: age and gender effectsP R Soria, J Vallejo, M Oros, et al.
Psychological Medicine|March 1, 1996
Growth hormone response to growth hormone releasing hormone in non-delusional and delusional depression and healthy controlsF Contreras, M A Navarro, J M Menchon, et al.
Journal of Endocrinological Investigation|March 28, 2020
Vitamin D status and response to growth hormone treatment in prepubertal children with growth hormone deficiencyT Durá-Travé, F Gallinas-Victoriano, P Moreno-González, et al.
The Pharmacogenomics Journal|May 17, 2007
A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disordersM Gratacòs, V Soria, M Urretavizcaya, et al.
Genes, Brain, and Behavior|July 13, 2010
A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depressionE Saus, V Soria, G Escaramís, et al.
Translational Psychiatry|February 8, 2017
Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging studyM Cano, I Martínez-Zalacaín, Á Bernabéu-Sanz, et al.
Pageof 2